Ardelyx (ARDX) Cash from Investing Activities (2013 - 2026)

Ardelyx (ARDX) posted Cash from Investing Activities of -$10.0 million for Q1 2026, down 364.7% on a QoQ basis from $3.8 million in Q4 2025, and down 450.58% year-over-year from $2.9 million in Q1 2025.

Ardelyx (ARDX) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Ardelyx's Cash from Investing Activities history runs 14 years deep, the most recent figure standing at -$10.0 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 450.58% year-over-year to -$10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.8 million (down 69.1% YoY) and the FY2025 annual result came in at -$9.0 million, up 51.09% from the prior year.
  • Cash from Investing Activities was -$10.0 million for Q1 2026 at Ardelyx, down from $3.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $34.9 million in Q2 2025 and bottomed at -$59.2 million in Q2 2023.
  • A 5-year average of -$8.8 million and a median of -$832000.0 in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities slumped 3829.93% — and 2025, when it jumped 210.85%.
  • Ardelyx's Cash from Investing Activities stood at $1.4 million in 2022, then plunged by 2151.84% to -$29.6 million in 2023, then tumbled by 40.77% to -$41.6 million in 2024, then jumped by 109.07% to $3.8 million in 2025, then plunged by 364.7% to -$10.0 million in 2026.
  • Business Quant data shows ARDX's Cash from Investing Activities at -$10.0 million in Q1 2026, $3.8 million in Q4 2025, and -$50.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 172.62 Mn
10 Ardelyx 1.24 Bn 999.81 Mn 89.66 Mn -10.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.00 Mn
Mar 31, 2026 -10.00 Mn
Dec 31, 2025 3.78 Mn
Dec 31, 2025 3.78 Mn
Sep 30, 2025 -50.51 Mn
Sep 30, 2025 -50.51 Mn
Jun 30, 2025 34.92 Mn
Jun 30, 2025 34.92 Mn
Mar 31, 2025 2.85 Mn
Mar 31, 2025 2.85 Mn
Dec 31, 2024 -41.62 Mn
Dec 31, 2024 -41.62 Mn
Sep 30, 2024 2.34 Mn
Sep 30, 2024 2.34 Mn
Jun 30, 2024 23.53 Mn
Jun 30, 2024 23.53 Mn
Mar 31, 2024 -2.57 Mn
Mar 31, 2024 -2.57 Mn
Dec 31, 2023 -29.57 Mn
Dec 31, 2023 -29.57 Mn